Skvarka Jan — insider trades

Stock trades Skvarka Jan reported on SEC Form 4 at ZNTL Zentalis Pharmaceuticals, Inc..

• Jan 31, 2025: bought 60,000 shares of ZNTL Zentalis Pharmaceuticals, Inc. ($103K)